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BACKGROUND
Rainbow Trout Fry Syndrome (RTFS) is caused by a gram-negative, rod-like, filamentous bacterium, •	 Flavobacterium 
psychrophilum. The disease is also known as bacterial cold water disease.
RTFS is a significant systemic bacterial disease with a worldwide distribution. •	 F. psychrophilum can affect all species  
of salmonid fish and is also known to cause disease in a range of other fish species such as eel, carp and tench.
RTFS can cause high mortalities (10% – 30%) or it can result in a failure of the fish to thrive.•	
The disease affects rainbow trout ranging in size from 0.2g – 100g at water temperatures of <10°C. •	
CLINICAL SIGNS
Affected fish become lethargic, stop feeding, exhibit an abnormal spiral swimming behaviour and swim close  •	
to the inlet/outlet pipes or close to the side of the tanks. 
The fish become dark with pale gills, swollen eyes, distended abdomen and exhibit a reddening of the vent.  •	
External lesions such as skin ulceration are more often seen in older fish. 
Internally the spleen is swollen, and there may be bloody fluid in the body cavity.•	
RAINBOW TROUT FRY SYNDROME
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DIAGNOSIS
Histopathological examination can reveal dramatic inflammation around the spleen.•	
Flavobacterium psychrophilum•	  is a relatively fastidious organism which grows best at 15oC on selective agar plates.
F. psychrophilum•	  grows as moist, yellow, raised and convex colonies on Anacher & Ordhal’s medium after three to  
six days incubation.
Serological and molecular based methods are also available for detection of the pathogen.•	
CONTROL
Disease spread can occur both through horizontal transmission (through the water and infected fish) and vertical •	
transmission from broodfish to offspring.
Incoming stock should be screened for the disease and only disease free fish stocked. •	
Antimicrobial therapy is the most effective method of control, however resistance is widespread.  •	
(All antibiotic treatment requires veterinary supervision and a prescription).
There is no commercial vaccine available although a number are at the experimental stage.•	
WHAT SHOULD I DO?
Minimise potentially stressful procedures such as handling and grading when RTFS is suspected or confirmed.•	
As RTFS is not listed under Council Directive 2006/88/EC, control of the disease is a matter for the operator and the •	
retained veterinary practitioner.
Strict biosecurity measures should be implemented around the infected site.•	
Remove moribund and dead fish from infected tanks daily. Mortalities should be disposed of in accordance with  •	
current Animal By-Products Regulations.
If the vet notices a change in the nature of the infection and suspects a more virulent disease is emerging or •	
alternatively, if a disease is suspected in a new host species, you should contact the Fish Health Unit of the  
Marine Institute. If you suspect the presence of a listed disease you should also notify the Marine Institute.
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